Showing 291-300 of 2105 results for "".
The Minimal Clinically Important Difference and Its Use in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-minimal-clinically-important-difference-and-its-use-in-neuromuscular-disorders/35532/The minimal clinically important difference facilitates the determination of clinically important and relevant outcome measures in clinical trials and clinical applications and is a promising alternative to statistical significance.Epilepsy Essentials: Caregiver Response to Genetic Diagnosis of Developmental and Epileptic Encephalopathy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-caregiver-response-to-genetic-diagnosis-of-developmental-and-epileptic-encephalopathy/31956/Anthropologic methodologies can aid in understanding the needs of caregivers and how physicians can support them.The Whole Physician: Ten Action Items to Combat Peer-to-Peer and Institutional Racial Bias in Medicine
https://practicalneurology.com/columns/practice-management/the-whole-physician-ten-action-items-to-combat-peer-to-peer-and-institutional-racial-bias-in-medicine/32106/Biases that exist in medicine can be remedied with actions tailored to the individual, specific groups, and society at large.Rapidly Progressive Dementia and Plateau Waves: A Rare Presentation of Leptomeningeal Disease
https://practicalneurology.com/programs/practical-neurology/rapidly-progressive-dementia-and-plateau-waves-a-rare-presentation-of-leptomeningeal-disease/33145/The authors present a rare clinical marker in a patient with rapidly progressive dementia which can aid appropriate diagnostic evaluation.In-Focus: Advocate for Medicine
https://practicalneurology.com/columns/practice-management/in-focus-advocate-for-medicine/30325/Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.Monitoring Disease Course and Treatment Response in Various Populations With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monitoring-disease-course-and-treatment-response-in-various-populations-with-multiple-sclerosis/33144/Monitoring for signs of disease activity or progression in multiple sclerosis—a crucial component of disease management—may need refinement for pediatric, pregnant or postpartum, older, and minority or underserved populations.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Addressing Lifestyle Factors in Poststroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/addressing-lifestyle-factors-in-poststroke-care/31963/Improved nutritional status can improve vascular risk factors, prevent recurrent stroke, and optimize poststroke outcomes.Poststroke Recrudescence:
Current Evidence and Considerations for Clinical Practicehttps://practicalneurology.com/diseases-diagnoses/stroke/poststroke-recrudescencebrcurrent-evidence-and-considerations-for-clinical-practice/32073/Despite the high prevalence of recrudescence after stroke and the importance of correct identification of recurrent cerebral ischemia, poststroke recrudescence is poorly understood.